Concepedia

Yumiko Shiraishi

YS

3

Publications

75

Citations

3

H-Index

2002

Active since

Affiliations

Zeria Pharmaceutical (Japan)(Current)

Central Research Laboratories (United Kingdom)

Yumiko Shiraishi is an author at Zeria Pharmaceutical (Japan) specializing in medicine, tumor immunity, and immunology.

Top concepts

Publications per year

2002–2004

3

Publications

3

Antimetastatic Effect of an Immunomodulatory Arabinomannan Extracted from Mycobacterium tuberculosis Strain Aoyama B, Z-100, through the Production of Interleukin-12

Hideki Oka, Yumiko Shiraishi, Hidetaka Sasaki et al. · Biological and Pharmaceutical Bulletin · 2003 · 28 citations · Full text

, , +24

Anti‐Tumor Mechanism of Z‐100, an Immunomodulatory Arabinomannan Extracted from <i>Mycobacterium tuberculosis</i> Strain Aoyama B, on Pulmonary Metastases of B16F10 Melanoma: Restoration of Helper T Cell Responses via Suppression of Glucocorticoid‐Genesis

Hideki Oka, Yutaka Emori, Hidetaka Sasaki et al. · Microbiology and Immunology · 2002 · 24 citations · Full text

, , +23

Z-100, an Immunomodulatory Arabinomannan Extracted from Mycobacterium tuberculosis Strain Aoyama B, Augments Anti-tumor Activities of X-Ray Irradiation against B16 Melanoma in Association with the Improvement of Type 1T Cell Responses

Hideki Oka, Hidetaka Sasaki, Yumiko Shiraishi et al. · Biological and Pharmaceutical Bulletin · 2004 · 23 citations · Full text

Rows per page

1–3 of 3